Teladoc Health Inc (4LL) News

Cardiome Announces Management Transition

NASDAQ: CRME TSX: COM VANCOUVER, Aug. 3 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRMENASDAQ:/NASDAQ:TSX:NASDAQ:COM) today...

Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.

Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now Effective

NASDAQ: CRME TSX: COM VANCOUVER, May 19 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRMENASDAQ:/NASDAQ:TSX:NASDAQ:COM) today...

Cardiome Reports First Quarter Results

NASDAQ: CRME TSX: COM VANCOUVER, May 15 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRME/TSX:NASDAQ:COM) today reported financial...

Cardiome to Hold Conference Call

NASDAQ: CRME TSX: COM VANCOUVER, April 8 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRME/TSX:NASDAQ:COM) today announced that a...

Cardiome Discloses Chairman And CEO's Involuntary Share Sale

NASDAQ: CRME TSX: COM VANCOUVER, Nov. 28 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRMENASDAQ:/NASDAQ:TSX:NASDAQ:COM) today...

Cardiome Reports Third Quarter Results

NASDAQ: CRME TSX: COM VANCOUVER, Nov. 14 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRMENASDAQ:/NASDAQ:TSX:NASDAQ:COM) today...

Cardiome Announces Filing Of Shelf Registration Statement

NASDAQ: CRME TSX: COM VANCOUVER, Oct. 23 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRME/TSX:NASDAQ:COM) today announced that it...

Cardiome Provides Regulatory Update

NASDAQ: CRME TSX: COM VANCOUVER, Oct. 9 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRMENASDAQ:/NASDAQ:TSX:NASDAQ:COM) today...

Cardiome Reports Second Quarter Results

NASDAQ: CRME TSX: COM VANCOUVER, Aug. 12 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRME/TSX:NASDAQ:COM) today reported financial...

Cardiome to Release Second Quarter Results and Hold Conference Call

NASDAQ: CRME TSX: COM VANCOUVER, Aug. 11 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRME/TSX:NASDAQ:COM) today announced that it...

Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For KYNAPID(TM)

NASDAQ: CRME TSX: COM VANCOUVER and DEERFIELD, IL, Aug. 11 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ:CRME/TSX:NASDAQ:COM) and its...

Cardiome Announces Preferred Share Financing

NASDAQ: CRME TSX: COM VANCOUVER, July 23 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRME/TSX:NASDAQ:COM) today announced that it...

Cardiome Announces Positive Phase 2b Results For Oral Vernakalant

NASDAQ: CRME TSX: COM VANCOUVER, July 14 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRMENASDAQ:/NASDAQ:TSX:NASDAQ:COM) today...

Cardiome To Hold Conference Call

NASDAQ: CRME TSX: COM VANCOUVER, July 13 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRMENASDAQ:/NASDAQ:TSX:NASDAQ:COM) today...